Inhibitors de serine proteases, especially of the NS3 protease of the hepatitis C virus
申请人:VERTEX PHARMACEUTICALS INCORPORATED
公开号:EP2409985A2
公开(公告)日:2012-01-25
The present invention relates to compounds, methods and pharmaceutical compositions for inhibiting proteases, particularly serine proteases, and more particularly HCV NS3 proteases. The compounds, and the compositions and methods that utilize them, can be used, either alone or in combination to inhibit viruses, particularly HCV virus.
本发明涉及用于抑制蛋白酶,特别是丝氨酸蛋白酶,尤其是 HCV NS3 蛋白酶的化合物、方法和药物组合物。这些化合物以及利用它们的组合物和方法可单独或联合用于抑制病毒,特别是 HCV 病毒。